Dyazide and Minipress drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Dyazide and Minipress together. This study is created by eHealthMe based on reports of 12 people who take Dyazide and Minipress from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on hydrochlorothiazide; triamterene and prazosin hydrochloride (the active ingredients of Dyazide and Minipress, respectively), and Dyazide and Minipress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Dyazide?

Dyazide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. (latest outcomes from Dyazide 10,359 users)

What is Minipress?

Minipress has active ingredients of prazosin hydrochloride. It is often used in post-traumatic stress disorder. (latest outcomes from Minipress 1,745 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 21, 2019

12 people who take Dyazide, Minipress are studied.


Number of reports submitted per year:

Dyazide and Minipress drug interactions.

Most common drug interactions over time *:

< 1 month:

n/a

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:
  1. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  2. Acute myocardial infarction (acute heart attack)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  5. Arthralgia (joint pain)
  6. Cardiovascular disorder (heart diseases)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Dysphagia (condition in which swallowing is difficult or painful)
5 - 10 years:

n/a

10+ years:
  1. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  2. Acute myocardial infarction (acute heart attack)
  3. Dysthymic disorder (mild chronic depression disorder)
  4. Fall
  5. Gastric disorder (disease of stomach)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Hypertensive crisis
  8. Hypertensive encephalopathy (neurological dysfunction induced by malignant hypertension)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
not specified:
  1. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
  2. Drug ineffective
  3. Myalgia (muscle pain)
  4. Red blood cell sedimentation rate increased
  5. Thrombosis (formation of a blood clot inside a blood vessel)
  6. Weight decreased
  7. Acute circulatory failure (shock)
  8. Anorectal disorder
  9. Asthenia (weakness)
  10. Dyspnoea (difficult or laboured respiration)

Most common drug interactions by gender *:

female:
  1. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Cardiovascular disorder (heart diseases)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
  9. Drug ineffective
  10. Dysphagia (condition in which swallowing is difficult or painful)
male:
  1. Thrombosis (formation of a blood clot inside a blood vessel)
  2. Anorectal disorder
  3. Drug ineffective

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:
  1. Thrombosis (formation of a blood clot inside a blood vessel)
  2. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Dysphagia (condition in which swallowing is difficult or painful)
  6. Dyspnoea (difficult or laboured respiration)
  7. Dysthymic disorder (mild chronic depression disorder)
  8. Fall
  9. Gastric disorder (disease of stomach)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

* Approximation only. Some reports may have incomplete information.


Do you take Dyazide and Minipress?

You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Dyazide and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Minipress and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Dyazide and Minipress
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Dyazide and Minipress



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.